Amy B. Cadwallader

United States Pharmacopeial Convention — United States

Medicine · Health Sciences

9h-index500citations19works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hormonal and reproductive studies(6), Muscle metabolism and nutrition(4), Opioid Use Disorder Treatment(3), Forensic Toxicology and Drug Analysis(3), Effects and risks of endocrine disrupting chemicals(2)

Publications19 total

Oncology Drug Shortages: Impacts, Policy Reforms, and Advocacy Imperatives
The Cancer Journal·2025Open Access
Why Assuring the Quality of Antimicrobials Is a Global Imperative
The AMA Journal of Ethic·2024· 7 citedOpen Access
Why Should Clinicians Care About Global Medical Supply Chain Security?
The AMA Journal of Ethic·2024· 2 citedOpen Access
How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?
The AMA Journal of Ethic·2024· 3 citedOpen Access
Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?
The AMA Journal of Ethic·2022· 10 citedOpen Access
What Should Dietary Supplement Oversight Look Like in the US?
The AMA Journal of Ethic·2022· 13 citedOpen Access
Seven Points for Athletes to Consider Before Using a Dietary Supplement
The AMA Journal of Ethic·2022· 4 citedOpen Access
Position Paper
American Journal of Forensic Medicine & Pathology·2020· 59 citedOpen Access
The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response
Journal of Analytical Toxicology·2018· 63 citedOpen Access
Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers
The AMA Journal of Ethic·2017· 5 citedOpen Access
Westside Diversion Program
OSF Preprints (OSF Preprints)·2016Open Access
Designer Steroids and Prohormones in Dietary Supplements: A Strategy for Detection Using a Mammalian Cell‐Based Androgen Receptor BioAssay and GC/MS
The FASEB Journal·2015
Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances
International Journal of Sport Nutrition and Exercise Metabolism·2015· 13 cited
Mechanism of error caused by isotope‐labeled internal standard: accurate method for simultaneous measurement of vitamin D and pre‐vitamin D by liquid chromatography/tandem mass spectrometry
Rapid Communications in Mass Spectrometry·2014· 16 cited
The Androgen Receptor and Its Use in Biological Assays: Looking Toward Effect-Based Testing and Its Applications
Journal of Analytical Toxicology·2011· 24 citedOpen Access
Toxicological determination and <i>in vitro</i> metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time‐of‐flight mass spectrometry
Rapid Communications in Mass Spectrometry·2010· 109 cited
The abuse of diuretics as performance‐enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis
British Journal of Pharmacology·2010· 161 citedOpen Access
Effect of Anabolic−Androgenic Steroids and Glucocorticoids on the Kinetics of hAR and hGR Nucleocytoplasmic Translocation
Molecular Pharmaceutics·2010· 2 cited
Signal Sequences for Targeting of Gene Therapy Products to Subcellular Compartments: The Role Of CRM1 in Nucleocytoplasmic Shuttling of the Protein Switch
Pharmaceutical Research·2007· 9 cited

Frequent Co-authors

Francesco Botrè(3), Carol S. Lim(3), Xavier de la Torre(2), Thomas Gilson(2), Douglas E. Rollins(2), Rebecca Heltsley(2), Bob Murray(2), Alessandra Tieri(1), Sabina Strano Rossi(1), Jayne B. Morrow(1), Jeri D. Ropero‐Miller(1), Megan L. Catlin(1), Agnes D Winokur(1), Jessica L. Staymates(1), Shannan Williams(1), Jonathan G. McGrath(1), Barry K. Logan(1), Michael M. McCormick(1), Kurt B. Nolte(1), Mario Menéndez(1)